TABLE 1.
Subject or isolate | Treatment interrupted | Treatment continued | No. of weeks post-PTIa | Codonb
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
41 | 62 | 67 | 69 | 70 | 103 | 118 | 181 | 184 | 190 | 210 | 215 | 219 | ||||
Clade B consensus | M | A | D | T | K | K | V | Y | M | G | L | T | K | |||
3005 | ZDV/3TC | IDV/RTV | 0 | L | - | N | D | - | - | - | - | V | - | W | Y | - |
34 | M/L | - | N | D | - | - | V/I | - | M/V | - | L/W | Y | - | |||
36 | M | - | N | D | - | - | V/I | - | M/V | - | L/W | Y | - | |||
48 | - | - | N | D | - | - | V/I | - | - | - | L/W | D/N/Y | - | |||
3040 | d4T/3TC | LPV/RTV | 0 | - | - | N | T/A | R | - | - | Y/C | V | - | - | T/S | Q |
12 | - | - | N | T | R | - | - | - | V | - | - | - | Q | |||
16 | - | - | N | - | R | - | - | - | V | - | - | - | Q | |||
22 | - | - | N | - | R | - | - | - | M/V | - | - | - | Q | |||
24 | - | - | N | - | R | - | - | - | M/V | - | - | - | Q | |||
36 | - | - | N | - | R | - | - | - | - | - | - | - | Q | |||
3057 | d4T/3TC | IDV | 0 | L | V | - | T/A | K/R | - | - | - | V | - | - | - | K/Q |
7 | L | V | - | - | - | - | - | - | V | - | - | - | ||||
36 | L | V | - | - | - | - | - | - | - | - | - | - | - | |||
48 | L | V | - | - | - | - | - | - | - | - | - | - | - | |||
3151 | DDI/d4T/3TC/EFV | APV/RTV | 0 | L | - | N | D | R | - | I | C | V | S | W | F | Q |
16 | L | - | N | D | R | - | I | C | V | S | L/W | F | Q | |||
3167 | ZDV/3TC | NFV | 0 | - | - | - | - | - | - | - | - | V | - | - | - | - |
4 | - | - | - | - | - | - | - | - | V | - | - | - | - | |||
8 | - | - | - | - | - | - | - | - | V | - | - | - | - | |||
12 | - | - | - | - | - | - | - | - | M/V | - | - | - | - | |||
3158 | d4T/3TC | None | 0 | - | - | N | - | R | - | - | - | V | - | - | - | Q |
5 | - | - | N | - | R | - | - | - | V | - | - | - | Q | |||
12 | - | - | N | - | R | - | - | - | M/V | - | - | - | Q | |||
16 | - | - | N | - | R | - | - | - | M/V | - | - | - | Q |
PTI, partial treatment interruption.
Amino acid residues are indicated by single-letter abbreviations. The HIV-1 clade B consensus sequence is shown for comparison. Dashes indicate identity with the consensus sequence. ZDV, zidovudine; ddI, didanosine; EFV, efavirenz; IDV, indinavir; RTV, ritonavir; SQV, saquinavir; APV, amprenavir.